Synapse - Matthew Hellmann

Results (412)

Exon 20 mutations of the epidermal growth factor receptor (Egfr) in lung adenocarcinomas: Clinicopathologic factors and response to therapy

Meeting Abstract

Naidoo, J.; Sima, C. S.; Hellmann, M. D.; Arcila, M. E.; Rizvi, N. A.; Yu, H. A.
Journal of Thoracic Oncology (2014)

Fulltext@MSK | Save

Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing

Journal Article

Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Annals of Oncology (2014)

Fulltext@MSK | Save

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: Proposal for the use of major pathological response as a surrogate endpoint

Journal Article

Hellmann, M. D.; Chaft, J. E.; William, W. N.; Rusch, V.; Pisters, K. M. W.; Kalhor, N.; Pataer, A.; Travis, W. D.; Swisher, S. G.; Kris, M. G.
Lancet Oncology (2014)

Fulltext@MSK | Save

Response to erlotinib and prognosis for patients with de novo epidermal growth factor receptor (EGFR) T790M mutations

Meeting Abstract

Riely, G. J.; Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A phase II trial of paclitaxel, pemetrexed and bevacizumab in patients with untreated, advanced lung cancers

Meeting Abstract

Pietanza, M. C.; Hellmann, M. D.; Rizvi, N.; Azzoli, C. G.; Smith-Marrone, S.; Fiore, J.; Tyson, L. B.; Sumner, D. K.; Hergianto, A. B.; Kass, S. L.; more...
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

FGFR1 amplification is associated with improved survival in patients with early-stage squamous cell carcinomas of the lung (SQCLC)

Meeting Abstract

Hellmann, M. D.; Wynne, M.; Wang, L.; Kris, M. G.; Sima, C. S.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Tumor expression of TTF1 is associated with a doubling of overall survival in patients with advanced lung adenocarcinomas

Meeting Abstract

Hellmann, M. D.; Hilden, P. D.; Sima, C. S.; Kris, M. G.; Rekhtman, N.; Chaft, J. E.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

"Intention-to-treat" outcomes of sequential patients with stage IIIA lung adenocarcinomas treated with neoadjuvant chemotherapy with intent of surgical resection

Meeting Abstract

Hellmann, M. D.; Chaft, J. E.; Hilden, P. D.; Rusch, V. W.; Kris, M. G.
Journal of Thoracic Oncology (2013)

Fulltext@MSK | Save

Major pathologic response (<= 10% viable tumor) following neoadjuvant chemotherapy as a surrogate for overall survival in patients with pathologically documented stage IIIA (N2) lung adenocarcinomas